mTert induction in p21-positive cells counteracts capillary rarefaction and pulmonary emphysema
Open Access
- 29 February 2024
- journal article
- research article
- Published by Springer Nature in EMBO Reports
- Vol. 25 (3) , 1650-1684
Abstract
Lung diseases develop when telomeres shorten beyond a critical point. We constructed a mouse model in which the catalytic subunit of telomerase (mTert), or its catalytically inactive form (mTert CI ), is expressed from the p21 Cdkn1a locus. Expression of either TERT or TERT CI reduces global p21 levels in the lungs of aged mice, highlighting TERT non-canonical function. However, only TERT reduces accumulation of very short telomeres, oxidative damage, endothelial cell (ECs) senescence and senile emphysema in aged mice. Single-cell analysis of the lung reveals that p21 (and hence TERT) is expressed mainly in the capillary ECs. We report that a fraction of capillary ECs marked by CD34 and endowed with proliferative capacity declines drastically with age, and this is counteracted by TERT but not TERT CI . Consistently, only TERT counteracts decline of capillary density. Natural aging effects are confirmed using the experimental model of emphysema induced by VEGFR2 inhibition and chronic hypoxia. We conclude that catalytically active TERT prevents exhaustion of the putative CD34 + EC progenitors with age, thus protecting against capillary vessel loss and pulmonary emphysema.Keywords
This publication has 72 references indexed in Scilit:
- Myc represses the p21 (WAF1/CIP1) promoter and interacts with Sp1/Sp3Proceedings of the National Academy of Sciences, 2001
- Endothelial Cell Death and Decreased Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor 2 in EmphysemaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Inhibition of VEGF receptors causes lung cell apoptosis and emphysemaJournal of Clinical Investigation, 2000
- Vascular atrophy and VEGFR-2 signaling: old theories of pulmonary emphysema meet new dataJournal of Clinical Investigation, 2000
- Hematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1Science, 2000
- Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP)Nucleic Acids Research, 1997
- Reverse Transcriptase Motifs in the Catalytic Subunit of TelomeraseScience, 1997
- Inhibition of cyclin-dependent kinases by p21.Molecular Biology of the Cell, 1995
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Newer Aspects of the Pulmonary Vasculature in Chronic Lung DiseaseAngiology, 1968